IVVD: Invivyd, Inc. Stock

by  •  • Comments Off on IVVD: Invivyd, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 56.54
Enterprise Value ($M) -12.81
Book Value ($M) 67.54
Book Value / Share 0.56
Price / Book 0.84
NCAV ($M) 38.70
NCAV / Share 0.32
Price / NCAV 1.46

Profitability (mra)
Return on Invested Capital (ROIC) -2.46
Return on Assets (ROA) -0.79
Return on Equity (ROE) -0.95

Liquidity (mrq)
Quick Ratio 1.19
Current Ratio 1.62

Balance Sheet (mrq) ($M)
Current Assets 100.68
Assets 129.51
Liabilities 61.98
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 25.38
Operating Income -176.88
Net Income -169.93

Cash Flow Statement (mra) ($M)
Cash From Operations -170.49
Cash from Investing -0.14
Cash from Financing 39.33

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-12 13G/A Fmr Llc 4.80 -21.11
12-12 13D/A Polaris Venture Partners V, L.P. 6.80
11-14 13G/A Deep Track Capital, LP 9.17 21.71
11-14 13G/A Maverick Capital Ltd 9.90 25.92
11-08 13G/A Gv 2019, L.p. 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 384,671 1,210,234 31.78
2025-04-16 395,929 1,128,870 35.07
2025-04-15 253,941 892,974 28.44
2025-04-14 418,685 1,653,967 25.31

(click for more detail)

Similar Companies
IOVA – Iovance Biotherapeutics, Inc. IRON – Disc Medicine, Inc.
ITOS – iTeos Therapeutics, Inc. IXHL – Incannex Healthcare Inc.
JANX – Janux Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io